Efficacy of saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: A randomised controlled trial

Early Human Development

Volumn 89, Issue 12, 2013, Pages 1033-1036

  Serce, Ozge ^a   Benzer, Derya ^a   Gursoy, Tugba ^a   Karatekin, Guner ^a   Ovali, Fahri ^a  

^a Zeynep Kamil Maternity and Child Research and Training Hospital   (Turkey)

Author keywords

Necrotizing enterocolitis; Probiotics; Saccharomyces boulardii; Sepsis; Very low birth weight

Indexed keywords

ANTIINFECTIVE AGENT; PLACEBO; PLANT EXTRACT; SACCHAROMYCES BOULARDII EXTRACT; UNCLASSIFIED DRUG; PROBIOTIC AGENT;

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFICACY; ENTERIC FEEDING; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; SACCHAROMYCES BOULARDII; SEPSIS; VERY LOW BIRTH WEIGHT; DOUBLE BLIND PROCEDURE; ENTEROCOLITIS, NECROTIZING; MICROBIOLOGY; NONPARAMETRIC TEST; PHYSIOLOGY; PREMATURITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SACCHAROMYCES; TURKEY;

DOUBLE-BLIND METHOD; ENTEROCOLITIS, NECROTIZING; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; PROBIOTICS; PROSPECTIVE STUDIES; SACCHAROMYCES; SEPSIS; STATISTICS, NONPARAMETRIC; TURKEY;

EID: 84887610664     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2013.08.013     Document Type: Article

References (28)

1. Deshpande G., Rao S., Patole S., Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010, 125:921-930.
2. Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 1996, 43:409-432.
3. Lin P.W., Stoll B.J. Necrotizing enterocolitis. Lancet 2006, 368:1271-1283.
4. Lin H.C., Hsu C.H., Chen H.L., Chung M.Y., Hsu J.F., Lien R.I. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008, 122:693-700.
5. Gewolb I.H., Schwalbe R.S., Taciak V.L., Harrison T.S., Panigrahi P. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999, 80:F167-F173.
6. Stoll B.J., Gordon T., Korones S.B., Shankaran S., Tyson J.E., Bauer C.R., et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996, 129:63-71.
7. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
8. Deshpande G.C., Rao S.C., Keil A.D., Patole S.K. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med 2011, 9:92.
9. Costalos C., Skouteri V., Gounaris A., Sevastiadou S., Triandafilidou A., Ekonomidou C., et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003, 74:89-96.
10. Ovali F. Intrauterine growth curves for Turkish infants born between 25 and 42weeks of gestation. J Trop Pediatr 2002, 49:381-383.
11. Walsh M.C., Kliegman R.M., Fanaroff A.A. Necrotiing enterocolitis: a practitioner's perpective. Pediatr Rev 1988, 9:219-226.
12. Papile L.A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight less than 1500grams. J Pediatr 1978, 92:529-534.
13. Alfaleh K., Anabrees J., Bassler D., Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011, 3:CD005496.
14. Akisu M., Baka M., Yalaz M., Huseyinov A., Kultursay N. Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Eur J Pediatr Surg Oct. 2003, 13:319-323.
15. Czerucka D., Piche T., Rampal P. Review article: yeast as probiotics --Saccharomyces boulardii. Aliment Pharmacol Ther 2007, 15(26):767-778.
16. Ng S.C., Hart A.L., Kamm M.A., Stagg A.J., Knight S.C. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 2009, 15:300-310.
17. Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., Black R.E. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo controlled trials. Lancet Infect Dis 2006, 6:374-382.
18. Vanderhoof J.A., Whitney D.B., Antonson D.L., Hanner T.L., Lupo J.V., Young R.J. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999, 135:564-568.
19. McFarland L.V. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol May 14 2010, 16:2202-2222.
20. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-390.
21. Indrio F., Neu J. The intestinal microbiome of infants and the use of probiotics. Curr Opin Pediatr 2011, 23:145-150.
22. Schwiertz A., Gruhl B., Löbnitz M., Michel P., Radke M., Blaut M. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 2003, 54:393-399.
23. Mihatsch W.A., Vossbeck S., Eikmanns B., Hoegel J., Pohlandt F. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth weight infants: a randomized controlled trial. Neonatology 2010, 98:156e63.
24. Stratiki Z., Costalos C., Sevastiadou S., Kastanidou O., Skouroliakou M., Giakoumatou A., et al. The effect of a Bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev 2007, 83:575-579.
25. Indrio F., Riezzo G., Raimondi F., Bisceglia M., Cavallo L., Francavilla R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr 2008, 152:801-806.
26. Bisson J.F., Hidalgo S., Rozan P., Messaoudi M. Preventive effects of different probiotic formulations on travelers' diarrhea model in wistar rats: preventive effects of probiotics on TD. Dig Dis Sci 2010, 55:911-919.
27. Katakura Y., Sano R., Hashimoto T., Ninomiya K., Shioya S. Lactic acid bacteria display on the cell surface cytosolic proteins that recognize yeast mannan. Appl Microbiol Biotechnol 2010, 86:319-326.
28. Gobbetti M., Corsetti A., Rossi J. The sourdough microflora. Interactions between lactic acid bacteria and yeasts: metabolism of carbohydrates. Appl Microbiol Biotechnol 1994, 41:456-460.